Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan

2 abstracts

Abstract
Non-comparative, open-label, international, multicenter phase I/II study of nivolumab (NIVO) ± ipilimumab (IPI) in patients (pts) with recurrent/metastatic Merkel cell carcinoma (MCC) (CheckMate 358).
Org: Division of Medical Oncology, University of Washington and Fred Hutchinson Cancer Center, Seattle, WA, UCL Cancer Center, University College London, London, United Kingdom, Vall d’Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan,
Abstract
Geriatric assessment and management with question prompt list using a web-based application for elderly patients with cancer to communicate aging-related concerns: A randomized clinical trial (J-SUPPORT 2101 study).
Org: National Cancer Center Hospital East, Kashiwa, Japan, IMSUT Hospital, University of Tokyo, Shizuoka Cancer Center, Nagoya City University Graduate School of Medical Sciences,